Claude H. Nash (born 1943) was CEO of Bloodstone Ventures plc. from 2007 to 2010. From 2004 to 2006 he was vice president, research and development at the

University of Maryland Biotechnology Institute Formed in 1985, the University of Maryland Biotechnology Institute (UMBI) was created to provide a unified focus for Maryland's biotechnology research and education. Now it refers as Institute of Marine and Environmental Technology (IMET). In 2010, ...

. He previously cofounded, and was CEO and chairman of,

ViroPharma Incorporated ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on Virus#Role in ...

, a pharmaceutical company. Before founding ViroPharma, Nash was vice president of

infectious disease An infection is the invasion of tissue (biology), tissues by pathogens, their multiplication, and the reaction of host (biology), host tissues to the infectious agent and the toxins they produce. An infectious disease, also known as a transmis ...

and

cancer Cancer is a group of diseases involving Cell growth#Disorders, abnormal cell growth with the potential to Invasion (cancer), invade or Metastasis, spread to other parts of the body. These contrast with benign tumors, which do not spread. Po ...

research at the Schering-Plough Research Institute.

Education

Nash has a B.S. in

biology Biology is the scientific study of life and living organisms. It is a broad natural science that encompasses a wide range of fields and unifying principles that explain the structure, function, growth, History of life, origin, evolution, and ...

and

chemistry Chemistry is the scientific study of the properties and behavior of matter. It is a physical science within the natural sciences that studies the chemical elements that make up matter and chemical compound, compounds made of atoms, molecules a ...

from

Lamar University Lamar University (Lamar or LU) is a public university in Beaumont, Texas, United States. Lamar has been a member of the Texas State University System since 1995. It was the flagship institution of the former Lamar University System. As of the ...

, an M.S. in

microbiology Microbiology () is the branches of science, scientific study of microorganisms, those being of unicellular organism, unicellular (single-celled), multicellular organism, multicellular (consisting of complex cells), or non-cellular life, acellula ...

(1966) and a Ph.D. in microbial genetics and

biochemistry Biochemistry, or biological chemistry, is the study of chemical processes within and relating to living organisms. A sub-discipline of both chemistry and biology, biochemistry may be divided into three fields: structural biology, enzymology, a ...

(1969) from

Colorado State University Colorado State University (Colorado State or CSU) is a Public university, public Land-grant university, land-grant research university in Fort Collins, Colorado, United States. It is the flagship university of the Colorado State University Syst ...

Pharmaceutical career

From 1983 to 1994 Nash served as vice president for infectious disease and oncology at

Schering Plough Schering-Plough Corporation was an American pharmaceutical company. It was originally the U.S. subsidiary of the German company Schering AG, which was founded in 1851 by Ernst Christian Friedrich Schering. As a result of nationalization, it becam ...

Research Institute. During that time, he was involved in the discovery and development of numerous biological agents, antibiotics, and antifungals. Previously, he was head of biological research at

Sterling Drug Sterling Drug was an American based global pharmaceutical company. It was also known as Sterling Winthrop, Inc., after the merger with Winthrop-Stearns Inc. which itself resulted from the merger of Winthrop Chemical Company Inc. and Frederick Ste ...

, head of infectious disease at

SmithKline Beecham GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, w ...

, and head of Fermentation Technology Group at

Eli Lilly Eli Lilly (July 8, 1838 – June 6, 1898) was a Union Army officer, pharmacist, chemist, and businessman who founded Eli Lilly and Company. Lilly enlisted in the Union Army during the American Civil War and recruited a company of men to ...

. In 1997 Nash co-founded and, until 2000, was chairman, president and CEO of

, a pharmaceutical company based in

Exton, Pennsylvania Exton is a census-designated place (CDP) in West Whiteland Township in Chester County, Pennsylvania, United States. Its population was 5,622 at the 2020 census. The Exton Square Mall and Main Street at Exton are both located within Exton alon ...

. Under his leadership ViroPharma completed an

initial public offering An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors and usually also to retail (individual) investors. An IPO is typically underwritten by one or more investm ...

, raised capital through public and private financing, and filed various INDs and an

NDA NDA may stand for: Military * National Defence Academy (disambiguation) * National Defence Act, legislation for organizing and funding Canada's military * Naval Defence Act (disambiguation) * Niger Delta Avengers, a militant group in Nigeria's ...

for

pleconaril Pleconaril (Picovir) is an antiviral drug that was being developed by Schering-Plough for prevention of asthma exacerbations and common cold symptoms in patients exposed to picornavirus respiratory infections. Pleconaril, administered either oral ...

to treat the

common cold The common cold, or the cold, is a virus, viral infectious disease of the upper respiratory tract that primarily affects the Respiratory epithelium, respiratory mucosa of the human nose, nose, throat, Paranasal sinuses, sinuses, and larynx. ...

. Nash currently serves or has served on the boards of directors for

(1997–2002), Adolor Corporation (since January 2000), Accera Pharmaceuticals, NoCopi Technologies and The Burnham Institute.

Academic service and honors

In 1984–1985 he was president of the

Society for Industrial Microbiology The Society for Industrial Microbiology and Biotechnology (SIMB) is a nonprofit, international association dedicated to the advancement of microbiological sciences, especially as they apply to industrial products, biotechnology, materials, and pro ...

. He received the Charles Porter Award from the Society for Industrial Microbiology and is a member of American Academy of Microbiology,

Phi Kappa Phi The Honor Society of Phi Kappa Phi (or simply Phi Kappa Phi or ) is an honor society established in 1897 to recognize and encourage superior scholarship without restriction as to the area of study, and to promote the "unity and democracy of educa ...

Sigma Xi Sigma Xi, The Scientific Research Honor Society () is an international non-profit honor society for scientists and engineers. Sigma Xi was founded at Cornell University by a faculty member and graduate students in 1886 and is one of the oldest ...

. In 2002 he was honored as a distinguished alumnus of the College of Veterinary Medicine and Biomedical Sciences at

References

{{DEFAULTSORT:Nash, Claude H. 1943 births Living people American biochemists Businesspeople from Pennsylvania American pharmaceutical industry businesspeople Eli Lilly and Company people Fellows of the American Academy of Microbiology Lamar University alumni Members of Phi Kappa Phi